Corinna C. Zygourakis
University of California, San Francisco
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Corinna C. Zygourakis.
Pituitary | 2015
Corinna C. Zygourakis; John D. Rolston; Han S. Lee; Carlene Partow; Sandeep Kunwar; Manish K. Aghi
AbstractPurposePituicytomas and spindle cell oncocytomas (SCOs) are extremely rare neoplasms of the sellar and suprasellar region that can often mimic pituitary adenomas. To date, there are relatively few cases of pituicytomas and SCOs reported; and most of these are small case series. MethodsIn this paper, we provide a retrospective review of the treatment, imaging characteristics, post-operative course, and histopathology of five cases of pituicytomas and two SCOs treated at the University of California, San Francisco (UCSF) over a 10-year period from 2003 to 2013.ResultsWe find that pituicytomas and SCOs present similarly to pituitary adenomas, and look identical on CT or MR imaging. We histopathologically confirmed all pituicytomas with a combination of hematoxylin and eosin morphology and immunohistochemical positivity for vimentin and S100; SCOs stain for anti-mitochondrial antigen and endothelial membrane antigen. We observe positive thyroid transcription factor 1 (TTF1) immunohistochemistry in both cases of SCO, as well as in both of the cases of pituicytoma in which TTF1 staining was available.ConclusionsThis represents the largest single-institution case series of pituicytomas and SCOs to date, and also includes the first description of the management of a pregnant female with SCO. Our findings are consistent with the idea of common histogenesis for pituicytomas and SCOs, and also raise the possibility of more aggressive growth in SCOs as compared to pituicytomas.
World Neurosurgery | 2012
Melanie Hayden Gephart; Corinna C. Zygourakis; Robert T. Arrigo; Paul Kalanithi; Shivanand P. Lad; Maxwell Boakye
OBJECTIVE Venous thromboembolism (VTE), which includes deep venous thrombosis and pulmonary embolism, is a serious and potentially fatal surgical complication. The goal of our study was to examine preoperative characteristics, incidence, and outcomes of patients with VTE after elective thoracic/thoracolumbar level spine fusion. METHODS We identified 430,081 patients from the Nationwide Inpatient Sample database who underwent spinal fusion between 2002 and 2008. Patients undergoing thoracic/thoracolumbar level fusion (n = 8617) were found to have the greatest concurrent rate of VTE. We then performed multivariate analyses on this cohort to identify predictors of and outcomes after VTE in patients undergoing thoracic/thoracolumbar level fusion. RESULTS The overall VTE rate in spinal fusion surgery was 0.40% (cervical = 0.22%, thoracic/thoracolumbar = 1.90%, lumbar/lumbosacral = 0.49%, re-fusions = 0.64%, and fusions not otherwise specified = 0.84%). On multivariate logistic regression analysis of patients undergoing spinal fusion at the thoracic/thoracolumbar level, increasing age, Medicare insurance coverage (vs. private insurance), urban teaching hospital (vs. urban nonteaching hospital), combined anterior/posterior surgical approach (vs. posterior-only approach), and the presence of congestive heart failure or weight loss (Elixhauser comorbidity groups) were each independently associated with an increased odds ratio of VTE complication. VTE after thoracic/thoracolumbar surgery was significantly associated with longer hospital stays (16.6 vs. 6.74 days), increased total hospital costs (
JAMA Surgery | 2016
Corinna C. Zygourakis; Victoria Valencia; Christopher Moriates; Christy Boscardin; Sereina Catschegn; Alvin Rajkomar; Kevin J. Bozic; Kent Soo Hoo; Andrew N. Goldberg; Lawrence H. Pitts; Michael T. Lawton; R. Adams Dudley; Ralph Gonzales
260,208 vs.
Neurosurgery | 2017
Corinna C. Zygourakis; Malla Keefe; Janelle Lee; Julio Barba; Michael W. McDermott; Praveen V. Mummaneni; Michael T. Lawton
115,474), and increased mortality (4.33% vs. 0.33%). CONCLUSIONS Multivariate logistic regression analysis reveals age, insurance status, hospital type, combined anterior/posterior surgical approach, and the presence of congestive heart failure or weight loss to be independently associated with an increased odds ratio of VTE complication. This complication is associated with increased hospital costs, length of stay, and overall mortality.
Neurosurgery Clinics of North America | 2012
Seunggu J. Han; Corinna C. Zygourakis; Michael Lim; Andrew T. Parsa
Importance Despite the significant contribution of surgical spending to health care costs, most surgeons are unaware of their operating room costs. Objective To examine the association between providing surgeons with individualized cost feedback and surgical supply costs in the operating room. Design, Setting, and Participants The OR Surgical Cost Reduction (OR SCORE) project was a single–health system, multihospital, multidepartmental prospective controlled study in an urban academic setting. Intervention participants were attending surgeons in orthopedic surgery, otolaryngology–head and neck surgery, and neurological surgery (n = 63). Control participants were attending surgeons in cardiothoracic surgery, general surgery, vascular surgery, pediatric surgery, obstetrics/gynecology, ophthalmology, and urology (n = 186). Interventions From January 1 to December 31, 2015, each surgeon in the intervention group received standardized monthly scorecards showing the median surgical supply direct cost for each procedure type performed in the prior month compared with the surgeon’s baseline (July 1, 2012, to November 30, 2014) and compared with all surgeons at the institution performing the same procedure at baseline. All surgical departments were eligible for a financial incentive if they met a 5% cost reduction goal. Main Outcomes and Measures The primary outcome was each group’s median surgical supply cost per case. Secondary outcome measures included total departmental surgical supply costs, case mix index–adjusted median surgical supply costs, patient outcomes (30-day readmission, 30-day mortality, and discharge status), and surgeon responses to a postintervention study-specific health care value survey. Results The median surgical supply direct costs per case decreased 6.54% in the intervention group, from
Spine | 2016
Alexander A. Theologis; Liane Miller; Matt Callahan; Darryl Lau; Corinna C. Zygourakis; Justin K. Scheer; Shane Burch; Murat Pekmezci; Dean Chou; Bobby Tay; Praveen V. Mummaneni; Sigurd Berven; Vedat Deviren; Christopher P. Ames
1398 (interquartile range [IQR],
Journal of Neurotrauma | 2012
Maxwell Boakye; Robert T. Arrigo; Melanie Hayden Gephart; Corinna C. Zygourakis; Shivanand P. Lad
316-
Neurosurgery Clinics of North America | 2015
Corinna C. Zygourakis; James G. Kahn
5181) (10 637 cases) in 2014 to
Journal of Clinical Neuroscience | 2014
Corinna C. Zygourakis; Gurvinder Kaur; Sandeep Kunwar; Michael W. McDermott; Michelle Madden; Taemin Oh; Andrew T. Parsa
1307 (IQR,
Journal of Neurosurgery | 2012
Melanie Hayden Gephart; Robert M. Lober; Robert T. Arrigo; Corinna C. Zygourakis; Raphael Guzman; Maxwell Boakye; Michael S. B. Edwards; Paul G. Fisher
319-